Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma? - Wikidata - wikimedia - TriplyDB

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

http://www.wikidata.org/entity/Q37993124

about

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Standards of care for treatment of recurrent glioblastoma--are we there yet?PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.Molecularly targeted therapies for recurrent glioblastoma: current and future targets.Novel chemotherapeutics and other therapies for treating high-grade glioma.H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment.Trends in Malignant Glioma Monoclonal Antibody Therapy.

P2860

Q36428702-7690BF13-AF4B-424F-A86B-1228148B2AC7 Q36500401-C4364E55-3F20-4684-BEDC-EB75882D5881 Q38228356-34922288-5D66-4DCF-9754-7ABE3A934B08 Q38233171-DA779C62-431E-4654-ACF8-7D2F340B4B97 Q38272728-BE1E3E63-23C6-4F8A-8F48-533E7BEC4E30 Q38569802-82043F7C-99A5-4BBC-96C6-3B0AB01F4DED Q38942329-CF6CCD6E-DE66-468D-BE87-2EDBA53D0815 Q41857963-454E3983-7EA5-42A3-96F5-34808623105B Q54942652-4ED006B7-7984-4510-9D1A-DF3AED18C5F5

P2860

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

http://www.wikidata.org/entity/Q37993124

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@en

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@nl

type

label

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@en

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@nl

prefLabel

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@en

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@nl

P1433

Q37993124-98A4DB89-357C-4C3A-86A8-333E7FB29981

P1476

Q37993124-9EA904CE-9F24-4D86-A463-8386CF94A09E

P2093

Q37993124-828D77E7-B80A-4233-91B5-2D06706921DB

P2860

Q37993124-01C4AA9D-9EE8-4A9A-8AE3-D8BC83328091

Q37993124-038D9B9C-8A06-4E6A-92CB-2F800637A187

Q37993124-0B7BA8B2-676B-4066-8105-629AE7DFC93C

Q37993124-13A72D68-7AC9-483F-8BC0-482C48B9F82D

Q37993124-15EF7E3F-4DB9-433A-87E8-2E387D3CF58B

Q37993124-16DB5524-9B70-4F8A-B3EA-124C05841F7F

Q37993124-190710B1-9C9E-4466-8850-56D6FF75E498

Q37993124-19A71819-450B-40B7-9A84-5AF01083A954

Q37993124-1BC53AB4-483D-41E3-9B9B-D2CED2BC960C

Q37993124-1C675D11-09F4-4500-90BC-6A3122C7A746

P304

Q37993124-1D0E098D-136A-4EDB-8A80-93778A3E97CA

P31

Q37993124-0FF3C238-26A3-450D-BEEF-286C48676C09

P356

Q37993124-D5A333FF-BB14-4D48-9FD3-7CF59336C9DE

P407

Q37993124-5C717E18-26F6-4446-B608-1FF3C1948EF9

P433

Q37993124-DF696419-DAC5-447E-B63C-1EEB82385F71

P478

Q37993124-70FFA537-1137-49A4-8FE4-9D803EA91009

P50

Q37993124-0E5F2939-98CA-4104-A488-55DDCEC76504

P577

Q37993124-CE0AFDBC-DDAA-40F5-964E-566833255129

P698

Q37993124-D004BB76-4EC5-4B8E-9EE1-88F616B1A6D6

P921

Q37993124-470EA49B-BEB2-4FF6-8824-F2AB42A2B750

P356

13543784.2012.670219

P1433

Expert Opinion on Investigational Drugs

P1476

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

@en

P2093

Katharina Seystahl

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Molecular mechanisms and clinical applications of angiogenesis

P304

605-617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2012.670219

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22413865

http://www.w3.org/2001/XMLSchema#string

P921